Buy & Sell Atmos Energy Corporation (ATO) – Atmos Energy Corporation Price Today
Aura AI Summary
Key Stats
- $30.40BMarket Cap
- UtilitiesSector
- -5.92%3M Drawdown
- $39.90BEnterprise Value
- 2.2%Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 45 daysTypical Hold Time
Atmos Energy Corporation (ATO) is currently valued at a market capitalization of $30.40B, with an enterprise value of $39.90B. Over the past 52 weeks, Atmos Energy Corporation has traded between a low of $151.54 and a high of $192.25, highlighting its annual price range. Over the past three months, Atmos Energy Corporation has recorded a drawdown of -5.92%, reflecting recent price volatility. Atmos Energy Corporation offers a dividend yield of 2.2%, with the most recent dividend of $1.00 paid on 23 Feb 26. On average, investors hold Atmos Energy Corporation for approximately 45 days, indicating typical investor behavior on the platform.
About Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Most Recent News
Investec Bank discloses share dealings in Advanced Medical Solutions Group on May 11, 2026
Investec Bank plc, acting as advisor and joint broker to Advanced Medical Solutions Group plc, disclosed its share dealings on May 11, 2026. The bank purchased 269,588 ordinary shares at prices between 252.5 and 255 pence and sold 241,501 shares at p...
Rigel Pharmaceuticals inks deal with Arvinas and Pfizer for breast cancer drug VEPPANU, shares jump 10.7%.
Rigel Pharmaceuticals has entered an exclusive global licensing agreement with Arvinas and Pfizer to develop and commercialize VEPPANU, an oral PROTAC drug for advanced breast cancer. The FDA recently approved VEPPANU for estrogen receptor-positive, ...
AI stocks plunge as broad profit-taking hits semiconductors, cloud, and tech ETFs after Jim Cramer's reversal warning.
AI-related stocks, especially in semiconductors, cloud infrastructure, and tech ETFs, saw sharp declines following a warning from CNBC host Jim Cramer about a potential market reversal. The sell-off was broad, reflecting profit-taking in a crowded AI...
